Anne Clem Whitaker, Director at Valeant Pharmaceuticals International, Inc. (VRX), bought 7,500 shares at $234.00 ($1.8M) on 2015-05-26, disclosed to the SEC on 2015-05-27.
Open-market purchase of $1.8M VRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $234.00 | 2,500 | $585K | 33.2% |
| 2 | $235.00 | 5,000 | $1.2M | 66.8% |
| Total | $234.67 avg | 7,500 | $1.8M | 100% |
| Filing → |
| CREE | SELL | 2020-11-06 | $3.7M | — | Filing → |
| CREE | SELL | 2016-02-18 | $19K | — | Filing → |
| CREE | SELL | 2015-09-03 | $53K | — | Filing → |